What is Global NGS-based RNA-sequencing Market?
The Global NGS-based RNA-sequencing Market is a rapidly evolving field that involves the use of Next Generation Sequencing (NGS) technology to study RNA sequences. This technology has revolutionized the way we understand the complexity of gene expression, allowing us to delve deeper into the genetic code. The market encompasses various products and services related to RNA sequencing, including instruments, reagents, and software, as well as data analysis and interpretation services. The growth of this market is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing use of NGS in clinical diagnosis. The market is also influenced by the decreasing cost of sequencing, which has made it more accessible to a wider range of researchers and institutions.
Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing in the Global NGS-based RNA-sequencing Market:
The Global NGS-based RNA-sequencing Market is segmented based on the type of sequencing technology used. These include Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, and Nanopore Sequencing. Each of these technologies has its own unique advantages and applications. Sequencing by Synthesis, for example, is known for its high accuracy and is commonly used in whole-genome sequencing. Ion Semiconductor Sequencing, on the other hand, does not require any optical system and is thus more cost-effective. Single-molecule Real-time Sequencing allows for the direct detection of DNA synthesis, while Nanopore Sequencing is renowned for its ability to sequence long reads. These diverse technologies cater to different needs and preferences in the market, contributing to its overall growth.
Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others in the Global NGS-based RNA-sequencing Market:
The Global NGS-based RNA-sequencing Market finds its applications in various sectors such as Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, among others. In Research & Academia, NGS-based RNA sequencing is used to study gene expression, discover new genes, and understand disease mechanisms. Hospitals & Clinics use this technology for diagnostic purposes, to identify genetic disorders and guide treatment decisions. Pharmaceutical & Biotechnology Companies leverage NGS-based RNA sequencing in drug discovery and development, to understand the genetic basis of diseases and develop targeted therapies. Other sectors also benefit from this technology in various ways, further driving the growth of the market.
Global NGS-based RNA-sequencing Market Outlook:
Looking at the market outlook, the Global NGS-based RNA-sequencing Market has shown significant growth over the years. In 2023, the market was valued at US$ 2532.5 million. However, it is projected to reach a staggering US$ 7862.7 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 17.4% during the forecast period from 2024 to 2030. This growth can be attributed to the advancements in sequencing technologies, the increasing demand for personalized medicine, and the growing use of NGS in clinical diagnosis. The decreasing cost of sequencing has also played a crucial role in making this technology more accessible, thereby contributing to the market's expansion.
| Report Metric | Details |
| Report Name | NGS-based RNA-sequencing Market |
| Accounted market size in 2023 | US$ 2532.5 million |
| Forecasted market size in 2030 | US$ 7862.7 million |
| CAGR | 17.4% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific, Roche, Takara Bio, GENEWIZ, Hamilton, Macrogen, Zymo Research, Tecan Genomics |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
